Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Orange, California

Phase 2 colorectal cancer trials in Orange, CA

5 Phase 2 colorectal cancer studies are recruiting participants at sites in Orange as of November 18, 2026, according to ClinicalTrials.gov. Colorectal Phase 2 Trials can help you understand your options and connect with a study team.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Orange at a glance

  • 5 studies are recruiting at a site in Orange.
  • By phase: Phase 2 (5).
  • By sponsor: university, hospital or other (4), industry (1).
  • Most recent update to one of these records: November 3, 2026.

Studies recruiting in Orange

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT05673148 · updated
  2. Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Irvine
    Study site
    Chao Family Comprehensive Cancer Center, University of California, Irvine
    Registry record
    NCT07795749 · updated
  3. Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Irvine
    Study site
    Chao Family Comprehensive Cancer Center, University of California Irvine
    Registry record
    NCT06580002 · updated
  4. TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Teclison Ltd.
    Study site
    University of California, Irvine Medical Center
    Registry record
    NCT04701476 · updated
  5. Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Irvine
    Study site
    Chao Family Comprehensive Cancer Center, University of California Irvine
    Registry record
    NCT07447050 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Orange, CA on ClinicalTrials.gov.

Ask about studies near Orange

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call